BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32653201)

  • 1. Aberrant Expression of Gastric Carcinoma High Expressed Transcript 1 is a Diagnostic and Prognostic Biomarker in Human Cancer.
    Wang H; Meng F; Dong S
    J Natl Med Assoc; 2020 Dec; 112(6):602-612. PubMed ID: 32653201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of LncRNA GHET1 expression in various cancers: a systematic review and meta-analysis.
    Ye J; Sun H; Feng Z; Zhang Q; Xia Y; Ji Y; Zhang Q
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31227613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
    Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
    J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and Clinicopathological Significance of Long Noncoding RNA GHET1 in Human Solid Tumors: a Meta-Analysis.
    Zeng L; Yang M; Gao D; Li N
    Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Value of lncRNA GHET1 as a Prognostic Factor for Survival of Chinese Cancer Outcome: A Meta-Analysis.
    Song J; Chen X; Tian Q; Lun L; Wang Q; Wang H; Li X; Liu Z; Tian L; Jing X; Zhang Y; Tian R
    Dis Markers; 2019; 2019():5824190. PubMed ID: 31885739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological Significance of Long Non-Coding RNA GHET1 in Human Cancers: A Meta-Analysis.
    Poursheikhani A; Nokhandani N; Yousefi H; Rad DM; Sahebkar A
    Curr Pharm Biotechnol; 2020; 21(14):1422-1432. PubMed ID: 32720600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GHET1 acts as a prognostic indicator and functions as an oncogenic lncRNA in cervical cancer.
    Zhang Q; Zhang Y; Wang Y
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30948501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and Prognostic Value of Gastric Carcinoma Highly Expressed Transcript 1 in Cancer: A Meta-Analysis.
    Zhou X; Fan Y; He Y; Mou A; Wang F; Liu Y; Wu Z
    J Oncol; 2020; 2020():6341093. PubMed ID: 32908508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
    Jin L; He Y; Tang S; Huang S
    J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of long non-coding RNA GHET1 in cancers: a systematic review and meta-analysis.
    Wang D; Zhang H; Fang X; Zhang X; Liu H
    Cancer Cell Int; 2020; 20():109. PubMed ID: 32280301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on the role of GHET1 in different cancers.
    Ghafouri-Fard S; Ahmadi Teshnizi S; Hussen BM; Taheri M; Zali H
    Pathol Res Pract; 2023 Jul; 247():154545. PubMed ID: 37244053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
    Zhang G; Cai J
    J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA GHET1 promotes esophageal squamous cell carcinoma cells proliferation and invasion via induction of EMT.
    Liu H; Zhen Q; Fan Y
    Int J Biol Markers; 2017 Oct; 32(4):e403-e408. PubMed ID: 28983895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA TUG1 as a Potential Novel Biomarker for Predicting the Clinical Outcome of Cancer Patients: a Meta-Analysis.
    Li B; Shen S; Zhang W; Qi T; Hu Q; Cheng Y
    Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549987
    [No Abstract]   [Full Text] [Related]  

  • 17. Long noncoding RNA HOTAIR as an independent prognostic marker in cancer: a meta-analysis.
    Zhang S; Chen S; Yang G; Gu F; Li M; Zhong B; Hu J; Hoffman A; Chen M
    PLoS One; 2014; 9(8):e105538. PubMed ID: 25157956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of long non-coding RNA NEAT1 indicates poor prognosis of human cancer.
    Fang J; Qiao F; Tu J; Xu J; Ding F; Liu Y; Akuo BA; Hu J; Shao S
    Oncotarget; 2017 Jul; 8(28):45918-45927. PubMed ID: 28507281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
    Yang F; Xue X; Zheng L; Bi J; Zhou Y; Zhi K; Gu Y; Fang G
    FEBS J; 2014 Feb; 281(3):802-13. PubMed ID: 24397586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
    Zhang S; Qiu D; Xie X; Shen Y
    BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.